X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES ORCHID PHARMA LTD JUBILANT LIFE SCIENCES/
ORCHID PHARMA LTD
 
P/E (TTM) x 17.8 -0.2 - View Chart
P/BV x 4.7 0.2 2,943.4% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 JUBILANT LIFE SCIENCES   ORCHID PHARMA LTD
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
ORCHID PHARMA LTD
Sep-13
JUBILANT LIFE SCIENCES/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs187194 96.3%   
Low Rs6535 186.0%   
Sales per share (Unadj.) Rs364.3276.5 131.8%  
Earnings per share (Unadj.) Rs6.8-79.2 -8.6%  
Cash flow per share (Unadj.) Rs24.5-43.5 -56.4%  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %2.40-  
Book value per share (Unadj.) Rs164.953.9 305.7%  
Shares outstanding (eoy) m159.2870.45 226.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.30.4 83.5%   
Avg P/E ratio x18.4-1.4 -1,272.8%  
P/CF ratio (eoy) x5.1-2.6 -195.1%  
Price / Book Value ratio x0.82.1 36.0%  
Dividend payout %43.80-   
Avg Mkt Cap Rs m20,0618,067 248.7%   
No. of employees `0006.22.8 220.9%   
Total wages/salary Rs m11,0522,527 437.3%   
Avg. sales/employee Rs Th9,383.06,956.1 134.9%   
Avg. wages/employee Rs Th1,786.9902.5 198.0%   
Avg. net profit/employee Rs Th176.3-1,993.0 -8.8%   
INCOME DATA
Net Sales Rs m58,03419,477 298.0%  
Other income Rs m191407 46.8%   
Total revenues Rs m58,22419,884 292.8%   
Gross profit Rs m5,7861,103 524.8%  
Depreciation Rs m2,8122,519 111.6%   
Interest Rs m3,2375,227 61.9%   
Profit before tax Rs m-72-6,236 1.2%   
Minority Interest Rs m-28620 -1,451.8%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,145511 419.7%   
Tax Rs m696-125 -556.2%   
Profit after tax Rs m1,090-5,580 -19.5%  
Gross profit margin %10.05.7 176.1%  
Effective tax rate %-965.92.0 -48,110.4%   
Net profit margin %1.9-28.7 -6.6%  
BALANCE SHEET DATA
Current assets Rs m29,28011,014 265.8%   
Current liabilities Rs m38,91232,060 121.4%   
Net working cap to sales %-16.6-108.1 15.4%  
Current ratio x0.80.3 219.0%  
Inventory Days Days8495 88.9%  
Debtors Days Days5134 151.0%  
Net fixed assets Rs m55,71229,440 189.2%   
Share capital Rs m155705 21.9%   
"Free" reserves Rs m20,9682,043 1,026.5%   
Net worth Rs m26,2653,800 691.2%   
Long term debt Rs m17,1699,018 190.4%   
Total assets Rs m88,60646,510 190.5%  
Interest coverage x1.0-0.2 -506.3%   
Debt to equity ratio x0.72.4 27.5%  
Sales to assets ratio x0.70.4 156.4%   
Return on assets %4.9-0.8 -642.6%  
Return on equity %4.2-146.9 -2.8%  
Return on capital %11.6-3.7 -309.7%  
Exports to sales %37.837.9 99.8%   
Imports to sales %16.522.6 72.9%   
Exports (fob) Rs m21,9337,378 297.3%   
Imports (cif) Rs m9,5674,406 217.1%   
Fx inflow Rs m22,0047,513 292.9%   
Fx outflow Rs m11,7495,649 208.0%   
Net fx Rs m10,2551,865 550.0%   
CASH FLOW
From Operations Rs m8,0261,682 477.3%  
From Investments Rs m-1,744-9,860 17.7%  
From Financial Activity Rs m-4,4476,644 -66.9%  
Net Cashflow Rs m1,834-1,535 -119.5%  

Share Holding

Indian Promoters % 45.6 32.3 141.2%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 4.6 189.1%  
FIIs % 21.2 3.3 642.4%  
ADR/GDR % 0.0 4.6 -  
Free float % 21.1 55.3 38.2%  
Shareholders   23,815 84,811 28.1%  
Pledged promoter(s) holding % 15.9 54.9 28.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   PLETHICO PHARMA  SANOFI INDIA  DR. DATSONS LABS  DR. REDDYS LAB  NOVARTIS  

Compare JUBILANT LIFE SCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 290 Points; Realty and PSU Stocks Witness Selling(Closing)

After opening the day on a negative note, share markets in India continued their downtrend throughout the day and ended in red.

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY19); Net Profit Up 39.4% (Quarterly Result Update)

Jul 31, 2018 | Updated on Jul 31, 2018

For the quarter ended June 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 39.4% YoY). Sales on the other hand came in at Rs 21 bn (up 30.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY18); Net Profit Up 1.4% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 1.4% YoY). Sales on the other hand came in at Rs 23 bn (up 37.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

As the Rupee Takes a Record Plunge, These Pharma Stocks Gain the Most(Sector Info)

Sep 5, 2018

Most pharma stocks were trading with gains amid rupee's fresh fall. Does that mean pharma stocks are back in vogue?

Why Arun Jaitley's Demonetisation Defence Doesn't Add Up(Vivek Kaul's Diary)

Sep 5, 2018

The tax collected has gone up a little but the question is at what cost.

The Cream of Small Cap Stocks(Profit Hunter)

Sep 5, 2018

Akin to skimming the cream off milk, one needs to learn to skim the cream off small cap stocks.

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Sep 18, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS